Blood Cell Functions Explained | Red & White Cells & Platelets Science

The coagulation cascade is a complex series of enzymatic reactions that stops bleeding after blood vessel injury, involving two main pathways—the intrinsic pathway (activated by damaged endothelium) and the extrinsic pathway (activated by tissue factor)—which converge to activate thrombin, which then converts fibrinogen to fibrin strands that form a mesh holding the platelet plug together; this cascade includes negative feedback loops to prevent excessive clotting and deficiencies in specific clotting factors (such as VIII, IX, or XI) can lead to hemophilia.

The coagulation cascade is a complex system controlling blood clotting, with each step having both pro-coagulant accelerators and anti-coagulant brakes. When this system malfunctions, inappropriate clots form more easily. Stress, hypertension, and high blood sugar activate this pathway because the body interprets these conditions as hemorrhage threats, preparing to form protective clots. This evolutionary response was adaptive for survival in ancestral environments but becomes pathological in modern society with constant stress and carbohydrate consumption. Understanding this mechanism explains why controlling blood sugar, blood pressure, and stress is more important than simply lowering cholesterol for heart disease prevention.

The coagulation cascade is a series of enzymatic reactions that convert fibrinogen into fibrin to form a stable blood clot, involving two main pathways: the intrinsic pathway (activated by subendothelial collagen exposure, involving Factors XII, XI, IX, and VIII) and the extrinsic pathway (activated by tissue factor released from damaged tissue, involving Factor VII); both pathways converge at Factor X to activate prothrombin into thrombin, which then converts fibrinogen into fibrin fibers that trap red blood cells, with Factor XIII providing final stabilization of the fibrin meshwork.

The coagulation cascade is a sequential biochemical process that stops bleeding through clot formation, involving two main pathways—the extrinsic pathway triggered by tissue trauma releasing tissue factor that activates Factor VII to convert Factor X, and the intrinsic pathway triggered by blood cell damage or collagen exposure that activates Factor XII to sequentially convert Factors XI and IX; both pathways converge to form prothrombin activator (activated Factor X), which converts prothrombin to thrombin, which then converts fibrinogen to fibrin monomers, with Factor XIII stabilizing these monomers into cross-linked fibrin polymers that attract platelets and phospholipids to form a stable blood clot and achieve hemostasis.

The coagulation cascade is a series of reactions that leads to blood clot formation, involving 13 clotting factors (proteins except factor IV which is calcium). The process begins with platelet plug formation, followed by the extrinsic pathway (initiated by tissue thromboplastin) and intrinsic pathway (initiated by collagen exposure), both converging to form prothrombin activator. This converts prothrombin to thrombin, which then converts fibrinogen to fibrin, forming a stable clot. Factor XIII stabilizes the clot. Vitamin K is essential for synthesizing factors II, VII, IX, and X.

Pathology is the study of diseases - how they occur and develop. Blood is a connective tissue in liquid form that carries oxygen. Blood consists of plasma (55%) and formed elements (45%). Plasma contains water, proteins, and salts. Formed elements include red blood cells (erythrocytes, biconcave discs without nucleus, 7.5 micrometers, 120-day lifespan, 4.5-5.5 million/cmm), white blood cells (nucleated, 4,000-11,000/cmm, classified as agranulocytes and granulocytes), and platelets (small irregular fragments without nucleus, 2-4 micrometers, 7-14 days lifespan, 2-4 lakh/cmm).

Red blood cell pathology encompasses various conditions affecting RBC structure, function, and lifespan, classified morphologically by MCV (microcytic <80 fL, normocytic 80-100 fL, macrocytic >100 fL) and etiologically by decreased production (iron deficiency, B12/folate deficiency, thalassemia), increased destruction (hemolytic anemias like sickle cell, spherocytosis, PNH), or blood loss. Iron deficiency anemia, the most common worldwide, presents with microcytic hypochromic cells and pencil cells. Thalassemia involves globin chain synthesis defects (alpha on chromosome 16, beta on chromosome 11), with major forms requiring transfusions. Sickle cell anemia results from HbS polymerization under low oxygen, causing vaso-occlusive crises. PNH involves GPI-anchored protein deficiency leading to complement-mediated hemolysis.

This segment covers two important morphological abnormalities in blood cells. Stomatocytes are red blood cells with an oval central pallor appearing as an elongated slit, concave on one side only, observed in alcoholic cirrhosis, obstructive jaundice, and May-Hegglin anomaly. Döhle bodies are blue-staining cytoplasmic inclusions in neutrophils, representing rough endoplasmic reticulum remnants from immature granulocytes. They are 1-2 micrometers, well-defined, and appear in May-Hegglin anomaly, certain anemias, and infectious states like scarlet fever. Any variation in normal blood cell morphology indicates cellular pathology.

General pathology consists of three parts: pathological anatomy (morphological changes), pathophysiology (functions of sick organism), and clinical pathology (clinical manifestations). Pathophysiology studies causes, mechanisms, and laws of disease occurrence, development, and termination. Causes include external factors (physical: radiation, temperature; chemical: acids, alkalis, medications; biological: viruses, bacteria) and internal factors (hereditary, genetic defects). Conditions include environmental, lifestyle, and constitutional factors. The etiotropic principle targets specific causes for optimal treatment. Disease mechanisms include damage mechanisms and protective/compensatory mechanisms. The ratio between protection and damage determines prognosis. Peripheral blood contains erythrocytes, leukocytes (4-8 × 10^9/L), and thrombocytes. Leukocytes are divided into granulocytes (basophils 0-1%, eosinophils 2-4%, neutrophils 55-65%) and agranulocytes (lymphocytes 25-35%, monocytes). Bone marrow is located in flat bones and epiphyses of long bones. All blood cells originate from hematopoietic stem cells differentiating into lymphoid and myeloid lineages. Leukocytosis is physiological (after eating, exertion, pregnancy) or pathological (concentration from fluid loss, production from specific cell increases). Basophils contain heparin and histamine, indicating tissue necrosis or allergic reactions. Eosinophils contain histaminase, indicating allergic reactions, helminth infections, or infections with allergic reactions.

This comprehensive lesson covers blood cells and their clinical importance. White blood cells (leukocytes) are immune cells named from Greek 'leukos' (white) and 'kytos' (cells), circulating in blood, lymph, and lymphoid organs. Classified into granulocytes (40-80%), lymphocytes (20-40%), and monocytes (2-10%), they participate in innate immunity (immediate, non-specific response) and adaptive immunity (specific, memory-based response). Pathologies include autoimmune diseases, allergies, HIV/AIDS, and cancers. Diagnostic tests include hemogram, myelogram, and urine examination. Red blood cells (erythrocytes) transport oxygen via hemoglobin, are nucleus-free cells living 120 days with biconcave disc shape. Normal count is 4.5-5.5 million per mm³ (men) or 3.8-5.3 million per mm³ (women). Analysis evaluates hemoglobin, MCV, MCH, MCHC, hematocrit, and morphology. Abnormal shapes indicate diseases like sickle cell disease, thalassemia, or spherocytosis. Results outside normal ranges require medical interpretation.

Adaptive immunity allows the immune system to learn and adapt to specific pathogens. B-lymphocytes produce antibodies with unique binding sites for specific antigens. T-lymphocytes coordinate immune responses and destroy infected cells. Memory cells persist for years or decades, enabling rapid responses upon re-exposure. This system requires initial exposure to develop, taking days to weeks, but provides long-lasting protection. The principle of vaccination exploits this memory, introducing antigens to train the immune system without causing full disease.

Adaptive immunity consists of two main branches: humoral immunity mediated by B cells and cell-mediated immunity mediated by cytotoxic T cells. In humoral immunity, B cells recognize free extracellular antigens through their B cell receptors (BCRs), undergo receptor-mediated endocytosis, and present processed antigens via MHC class II molecules to activate T helper cells. Activated T helper cells secrete cytokines like IL-4 and IL-5 that stimulate B cell proliferation and differentiation into plasma cells (which secrete antibodies) and memory B cells. In cell-mediated immunity, cytotoxic T cells recognize infected or cancerous cells displaying foreign peptides on MHC class I molecules; upon recognition, they release perforin and granzymes that induce apoptosis in target cells. This dual system provides comprehensive protection against both extracellular pathogens (humoral) and intracellular pathogens/cellular damage (cell-mediated).

Adaptive immunity (acquired/specific immunity) develops after birth in response to pathogen exposure. It consists of T lymphocytes and B lymphocytes (20-40% of WBCs, total mass comparable to brain/liver). T cells include helper T cells (CD4+) that coordinate immune responses by secreting growth factors and cytokines essential for other cell maturation, and cytotoxic T cells (CD8+) that directly kill infected cells. AIDS destroys CD4+ T helper cells, crippling the immune system. B cells produce antibodies (Y-shaped proteins) that recognize and capture pathogen antigens. Upon first exposure, adaptive response is minimal but stores immunological memory. Subsequent exposures trigger amplified, specific responses. Humoral immunity (B cells/antibodies) and cellular immunity (T cells) work together to eliminate pathogens.

Adaptive immunity is acquired after birth through exposure to specific pathogens. When an organism encounters a particular pathogen, its immune system develops specific defenses against it. This type of immunity is specific to particular pathogens and provides long-lasting protection. If the same pathogen attacks again, the immune system can quickly recognize and eliminate it.

Adaptive immunity (third line of defense) is characterized by three key properties: (1) Acquired immunity - not innate but develops through exposure or vaccination, (2) Transferable immunity - can be transferred between individuals via serum containing antibodies, (3) Specificity - each pathogen requires its own specific antibody response. The mechanism involves B lymphocytes recognizing pathogens, proliferating, and differentiating into plasma cells that produce antibodies. These antibodies bind to specific antigens, forming immune complexes that neutralize pathogens and prevent their spread.

This comprehensive section covers the fundamental immunological principles underlying blood typing. It begins with defining antigens as molecular markers on cell surfaces that identify cell type, and antibodies as Y-shaped immunoglobulins produced by the immune system that specifically bind to particular antigens. The body normally eliminates self-reactive antibodies through tolerance mechanisms, but failure leads to autoimmune reactions. The lecture then transitions to the ABO blood group system, explaining how Type A expresses A antigens, Type B expresses B antigens, Type AB expresses both, and Type O expresses neither. The Rh system is introduced as determining D antigen presence (Rh positive) versus absence (Rh negative). Laboratory testing methods using anti-A and anti-B antibodies are explained, demonstrating how positive/negative reactions determine blood type through antigen-antibody binding.

Blood typing is based on antigens (sugar molecules) on red blood cell surfaces that determine identity. The ABO system classifies blood into four types: A (only A antigen), B (only B antigen), AB (both A and B antigens), and O (no antigens). Each blood type produces specific antibodies against foreign antigens: Type A produces anti-B antibodies, Type B produces anti-A antibodies, Type AB produces neither, and Type O produces both. This antigen-antibody relationship explains why incompatible blood transfusions trigger immune attacks, making proper blood typing essential for safe transfusions.

This segment covers essential hematology and immunology topics for FGV exams. ABO blood typing is defined by antigens on RBCs and natural antibodies in serum. Direct Coombs test detects antibodies or complement bound to RBC surface by adding patient RBCs with commercial antisera and antiglobulin reagent. Indirect Coombs test detects free antibodies in serum by adding patient serum with known antigen-positive RBCs, then adding antiglobulin reagent. Key distinction: direct test detects antibodies on RBC membrane, indirect test detects antibodies in serum. The antiglobulin reagent acts as an anti-antibody that bridges antibody Fc regions, making agglutination visible. Essential topics include RBC morphology alterations (drepanocytosis, sickle cell, target cells), hemoglobinopathies (thalassemias, sickle cell disease), antigen-antibody reactions, autoimmunity, and immunological techniques (ELISA, immunofluorescence, flow cytometry). Rapid test principles (chromatography) are also covered.

Blood types are determined by antigens on red blood cells: Type A (A antigen), Type B (B antigen), Type AB (both antigens), Type O (neither). Rh factor adds positive/negative classification. Blood typing uses agglutination: mixing blood with anti-A, anti-B, and anti-Rh antibodies. Agglutination indicates antigen presence. Immunity includes innate (non-specific, present at birth: skin, mucous membranes, tears, inflammatory response) and adaptive (specific, requires prior exposure, provides memory). Lymphocytes coordinate adaptive immunity: T cells direct responses, B cells produce antibodies (immunoglobulins: IgA, IgE, IgG, IgM, IgD).

Blood groups are determined by specific antigens on red blood cell surfaces. The ABO system classifies blood into four groups based on A and B antigens: Group I (O) has no antigens, Group II (A) has A antigen, Group III (B) has B antigen, and Group IV (AB) has both. The Rh system adds the D antigen classification (positive/negative). Antigens are molecular structures that can bind to antibodies; agglutinogens refer specifically to red blood cell antigens, while agglutinins are the corresponding antibodies. Each blood group produces antibodies against antigens it lacks: Group I produces anti-A and anti-B, Group II produces anti-B, Group III produces anti-A, and Group IV produces none. When incompatible blood is transfused, recipient antibodies attack donor antigens, causing dangerous agglutination reactions.